8 April 2019 April 2019 decisions news release Three new medicines accepted for use by NHSScotland The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 8 April) published advice accepting three new medicines.
11 March 2019 March 2019 decisions news release Two new medicines accepted for use in NHSScotland The Scottish Medicines Consortium (SMC), which provides advice to NHSScotland about the value for patients of every newly licensed medicine, has today (Monday 11 March) published advice accepting two new medicines.
11 February 2019 February 2019 decisions news release Innovative medicine for a rare blood cancer in children accepted for use in NHSScotland A medicine used to treat a rare blood cancer in children and young adults has today (Monday 11 February) been accepted by the Scottish Medicines Consortium (SMC) for use in NHSScotland.
14 January 2019 January 2019 decisions news release Medicines for breast cancer, psoriatic arthritis and diabetes accepted for use by NHSScotland A medicine used to treat advanced breast cancer has today (Monday 14 January) been accepted by the Scottish Medicines Consortium (SMC) for use in NHSScotland.
14 December 2018 SMC commitment to ensuring patients' voices are heard in HTA underlined by rise in submissions A rise in the number of medicines that are accompanied by a patient group submission has underlined SMC's commitment to ensuring the voice of patients are heard in the health technology assessment (HTA) process.
10 December 2018 December 2018 decisions news release Medicines for breast cancer, skin cancer and MS accepted for use by NHS A medicine used to treat early stage breast cancer has been accepted by the Scottish Medicines Consortium (SMC) for use in NHSScotland.
12 November 2018 November 2018 decisions news release Medicine for rare cancer in children accepted for use in NHSScotland A medicine used to treat a rare cancer which occurs predominantly in very young children has been accepted (Monday 12 November) by the Scottish Medicines Consortium (SMC) for routine use in NHSScotland.
8 October 2018 Revised process for ultra-orphan medicines New approach to assessment introduced Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the assessment of ultra-orphan medicines is being introduced.
8 October 2018 October 2018 decisions news release Medicines for leukaemia and arthritis among four accepted for use by NHSScotland The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 8 October) published advice accepting four new medicines.
10 September 2018 New summary documents help to explain SMC decisions to public Public friendly summaries of decisions launched To help further improve public understanding of our work, we have launched a new summary document which will accompany every medicine decision.
